03790nam 2200613Ia 450 991045179270332120200520144314.0(CKB)1000000000450725(EBL)3377460(SSID)ssj0000121215(PQKBManifestationID)11910125(PQKBTitleCode)TC0000121215(PQKBWorkID)10092857(PQKB)10465469(MiAaPQ)EBC3377460(Au-PeEL)EBL3377460(CaPaEBR)ebr10071490(OCoLC)923270744(EXLCZ)99100000000045072520050323d1995 uy 0engur|n|---|||||txtccrThe children's vaccine initiative[electronic resource] continuing activities : a summary of two workshops held September 12-13 and October 25-26, 1994 /Greg W. Pearson, editor ; Steering Committee on the Children's Vaccine Initiative: Continuing Activities, Division of Health Promotion and Disease Prevention, Institute of MedicineWashington, D.C. National Academy Press19951 online resource (65 p.)Committee chair: Caroline Breese Hall.Support for this project was provided by the Agency for International Development.A summary of two workshops held September 12-13 and October 25-26, 1994.0-309-57234-7 ""The Children�s Vaccine Initiative: Continuing Activities""; ""Copyright""; ""Preface""; ""Contents""; ""Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World""; ""INTRODUCTION""; ""ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD""; ""DETERMINING VACCINE NEED""; ""OVERCOMING SCIENTIFIC AND TECHNOLOGICAL BARRIERS""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS""; ""The Public-/Private-Sector Interface""; ""INTRODUCING AN EFFECTIVE VACCINE""""Involving the U.S. Public and Private Sectors in the CVI""""INTRODUCTION""; ""BRINGING CLARITY TO THE CVI “VISION�""; ""TRENDS IN THE GLOBAL VACCINE SITUATION""; ""Industry Characteristics""; ""Local Production and Self-Sufficiency""; ""RESHAPING THE EPI""; ""A ROLE FOR INDUSTRY""; ""Barriers to Participation""; ""FACILITATING GREATER U.S. INVOLVEMENT""; ""Differential Pricing""; ""Technology Transfer""; ""DISCUSSION SUMMARY""; ""Appendix A Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World""; ""FINAL AGENDA""; ""Day 1""; ""Day 2""""WORKSHOP SPEAKERS""""WORKSHOP PARTICIPANTS""; ""Staff""; ""Appendix B Involving the U.S. Public and Private Sectors in the CVI""; ""FINAL AGENDA""; ""Day 1""; ""Involving the U.S. Public and Private Sectors in the CVI""; ""WORKSHOP SPEAKERS""; ""COMMISSIONED PAPER""; ""WORKSHOP PARTICIPANTS""; ""Staff""; ""Appendix C Acronyms and Abbreviations""Vaccination of childrenVaccinesImmunization of childrenElectronic books.Vaccination of children.Vaccines.Immunization of children.614.47Pearson Greg W964533Hall Caroline Breese964534Institute of Medicine (U.S.).Steering Committee on the Children's Vaccine Initiative: Continuing Activities.Institute of Medicine (U.S.).Division of Health Promotion and Disease Prevention.MiAaPQMiAaPQMiAaPQBOOK9910451792703321The children's vaccine initiative2188451UNINA